Phase 1b-2a study to reverse platinum resistance through use of a hypomethylating agent, azacitidine, in patients with platinum-resistant or platinum-refractory epithelial ovarian cancer

Siqing Fu, Wei Hu, Revathy Iyer, John J. Kavanagh, Robert L. Coleman, Charles F. Levenback, Anil K. Sood, Judith K. Wolf, David M. Gershenson, Maurie Markman, Bryan T. Hennessy, Razelle Kurzrock, Robert C. Bast

Research output: Contribution to journal › Article › peer-review

147 Scopus citations

Fingerprint

Dive into the research topics of 'Phase 1b-2a study to reverse platinum resistance through use of a hypomethylating agent, azacitidine, in patients with platinum-resistant or platinum-refractory epithelial ovarian cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences